SOURCE: MMRGlobal, Inc.

MMRGlobal, Inc.

December 12, 2011 07:20 ET

MMRGlobal Signs $30 Million Non-Exclusive Patent License Agreement

LOS ANGELES, CA--(Marketwire - Dec 12, 2011) - MMRGlobal, Inc. (OTCBB: MMRF) ("MMR") (the "Company") today announced that on December 9, 2011 it signed a Settlement and Patent License Agreement (the "Agreement") with Surgery Center Management LLC ("SCM") to license certain of the Company's Health IT and Personal Health Record patents, including various patents covering uses of MMR's personal and professional Health IT products and services. These include the Company's ( Personal Health Record and MMRPro ( document imaging and scanning solutions for healthcare professionals (the "Licensed Patents") for a payment of $30 million plus additional usage royalties as outlined in the Agreement. The Agreement specifically excludes any of MMRGlobal's biotech assets.

Under the terms of the Agreement, MMR shall issue a limited, non-exclusive, non-transferable license to the Licensed Patents which cover the Licensed Products and/or Licensed Services to develop, make, have made, use, sell, lease, license, demonstrate, market and distribute the Licensed Products and/or Licensed Services under Licensee's brand, or private labeled for channel or distribution partners who purchase the Licensed Products and/or Licensed Services for resale to end customers. The Licensed Patents shall mean any issued or pending U.S. and/or foreign patent applications and/or issued patents including but not necessarily limited to Singapore, Hong Kong, Israel, South Korea, Mexico, New Zealand, Canada, Germany, Japan, United Kingdom, and the United States. The Agreement includes settlement of any potential claims by MMRGlobal against SCM and its affiliates for any past patent infringement.

"Last year, MMRGlobal celebrated the New Year by announcing a $13 million biotech licensing agreement. This year, MMR will go into the New Year announcing a $30 million licensing agreement. These license agreements highlight the potential value in the Company's patents and other Intellectual Property," said Robert H. Lorsch, Chairman and CEO of MMRGlobal.

The Agreement also contains customary provisions for this type of Agreement, such as the term of the Agreement, terms for payment, warranties and representations of the parties, and indemnities by the Company and SCM to each other. Although the effective date of the Agreement is December 9th, certain material rights and releases contained in the Agreement require that SCM pay the entire $30 million to MMR before those rights and releases become effective without which MMRGlobal would not have entered into the Agreement. The Company intends to file the Agreement as an exhibit to the Company's Annual Report on Form 10K.

In addition to holding numerous patents for Health IT applications, which are already being successfully licensed worldwide, the Company controls a portfolio of biotech assets acquired through a reverse merger with Favrille, Inc. in 2009. Favrille spent more than $100 million in development of certain intellectual property that includes biotech patents and patient samples, which MMR is working to license to biotech companies, universities and others. As previously reported, the Company has already demonstrated its ability to license portions of these biotech assets.

About MMRGlobal, Inc.

MMRGlobal, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc. ("MMR") (, provides secure and easy-to-use online Personal Health Records ("PHRs") and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, and professional organizations and affinity groups. MyMedicalRecords enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. The MyMedicalRecords Personal Health Record is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user's account. The Company's professional offering, MMRPro, is designed to give physicians' offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients in real time through an integrated patient portal. MMR is an Independent Software Vendor Partner with Kodak to deliver an integrated turnkey EMR solution for healthcare professionals. Through its merger with Favrille, Inc. in January 2009, the Company acquired intellectual property biotech assets that include anti-CD20 antibodies and data and samples from its FavId™/Specifid™ vaccine clinical trials for the treatment of B-Cell Non-Hodgkin's lymphoma. To learn more about MMRGlobal, Inc. and its products, visit

Forward-Looking Statements

All statements in this press release that are not strictly historical in nature, whether or not such statement relates directly to the Agreement between MMRGlobal, Inc. and Surgery Center Management, LLC signed on December 9, 2011 or the terms contained therein, and the Company's future performance, management's expectations, beliefs, intentions, estimates or projections, constitute "forward-looking statements." Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. Some can be identified by the use of words (and their derivations) such as "need," "possibility," "offer," "development," "if," "negotiate," "when," "begun," "believe," "achieve," "will," "estimate," "expect," "maintain," "plan," and "continue," or the negative of these words. Factors that could cause or contribute to such differences include, but are not limited to, the risk that Surgery Center Management, LLC could terminate the Settlement and Patent License Agreement as a result of any inability on the part of the Company to perform any of its obligations under the Agreement or any legal or regulatory matters affecting SCM's ability to utilize any portion of the Licensed Patents. The Company is providing this information as of the date of this release and, except as required by law, does not undertake any obligation to update any forward-looking statements contained in this release as a result of new information, future events or otherwise. You are cautioned not to place undue reliance on the forward-looking statements set forth in this press release.

Contact Information